Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.
da Costa AABA, do Canto LM, Larsen SJ, Ribeiro ARG, Stecca CE, Petersen AH, Aagaard MM, de Brot L, Baumbach J, Baiocchi G, Achatz MI, Rogatto SR. da Costa AABA, et al. BMC Cancer. 2019 May 6;19(1):422. doi: 10.1186/s12885-019-5622-4. BMC Cancer. 2019. PMID: 31060523 Free PMC article.
Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
Cotrim DP, Ribeiro ARG, Paixão D, de Queiroz Soares DC, Jbili R, Pandolfi NC, Cezana C, de Cássia Mauro C, Mantoan H, Bovolim G, de Brot L, Torrezan GT, Carraro DM, Baiocchi G, da Cruz Formiga MN, da Costa AABA. Cotrim DP, et al. Among authors: da costa aaba, da cruz formiga mn. BMC Cancer. 2019 Jan 3;19(1):4. doi: 10.1186/s12885-018-5235-3. BMC Cancer. 2019. PMID: 30606148 Free PMC article.
The Impact of Addition of Consolidation Chemotherapy to Standard Cisplatin-Based Chemoradiotherapy in Uterine Cervical Cancer: Matter of Distant Relapse.
Fabri VA, Queiroz ACM, Mantoan H, Sanches SM, Guimarães APG, Ribeiro ARG, Souza RP, Maya JML, Santos ES, Castro FS, Lima JPNS, Chen MJ, Baiocchi G, da Costa AABA. Fabri VA, et al. Among authors: da costa aaba. J Oncol. 2019 Mar 11;2019:1217838. doi: 10.1155/2019/1217838. eCollection 2019. J Oncol. 2019. PMID: 30984261 Free PMC article.
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer.
LaFargue CJ, Handley KF, Fleming ND, Nick AM, Chelariu-Raicu A, Fellman B, Castellano T, Ogasawara A, Hom-Tedla M, Blake EA, da Costa AABA, Crim AK, Rauh-Hain A, Westin SN, Coleman RL, Matsuo K, Baiocchi G, Hasegawa K, Moore K, Sood AK. LaFargue CJ, et al. Among authors: da costa aaba. Gynecol Oncol. 2022 Apr;165(1):82-89. doi: 10.1016/j.ygyno.2022.02.006. Epub 2022 Feb 23. Gynecol Oncol. 2022. PMID: 35216808 Free PMC article.
PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer.
Ravindranathan R, Somuncu O, da Costa AABA, Mukkavalli S, Lamarre BP, Nguyen H, Grochala C, Jiao Y, Liu J, Kochupurakkal B, Parmar K, Shapiro GI, D'Andrea AD. Ravindranathan R, et al. Among authors: da costa aaba. Proc Natl Acad Sci U S A. 2024 Nov 19;121(47):e2413954121. doi: 10.1073/pnas.2413954121. Epub 2024 Nov 15. Proc Natl Acad Sci U S A. 2024. PMID: 39546575
41 results